• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Novo Nordisk

7 medtech advances to improve diabetes treatment

January 10, 2020 By Sean Whooley

Medtech and pharmaceutical companies have made several important strides over the past year when it comes to improving diabetes treatment. Multiple treatments and technologies have cleared regulatory hurdles and are now hitting the market and making the process of living with diabetes that much more manageable. Several different styles of therapy and devices have come […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance, Software / IT Tagged With: DarioHealth Corp, FDA, Medtronic, Novo Nordisk, One Drop, OptiScan, popsdiabetescare, Senseonics, tandemdiabetes, Valeritas

Insulet wins FDA nod for Omnipod with Novo Nordisk’s Fiasp insulin

October 28, 2019 By Sean Whooley

Insulet (NSDQ:PODD) said last week that it won FDA clearance for the use of Novo Nordisk‘s (NYSE:NVO) Fiasp insulin with the Omnipod insulin management platform. Acton, Mass.-based Insulet said it completed extensive testing to ensure that Fiasp is safe and usable with the Omnipod and Omnipod Dash systems. It’s the first insulin pump in the U.S. […]

Filed Under: Diabetes, Drug-Device Combinations, Food & Drug Administration (FDA) Tagged With: FDA, Insulet, Novo Nordisk

FDA OKs Novo Nordisk’s Fiasp for infusion pumps

October 22, 2019 By Sean Whooley

Novo Nordisk (NYSE:NVO) said today that it won an expanded label from the FDA for its Fiasp fast-acting insulin aspart injection for use with infusion pumps by adults with Type 1 or Type 2 diabetes. Fiasp won FDA approval in 2017 for use in intravenous infusion under professional supervision or by subcutaneous multiple daily injection in […]

Filed Under: Diabetes, Drug-Device Combinations, Food & Drug Administration (FDA) Tagged With: FDA, Novo Nordisk

Abbott, Medtronic ink diabetes pacts with Sanofi, Novo Nordisk

September 16, 2019 By Danielle Kirsh

Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) today announced separate data-sharing deals for digital diabetes management solutions. Abbott is partnering with Sanofi (NYSE:SNY) to integrate glucose sensing and insulin delivery to help people manage their diabetes. The two companies plan to develop tools to combine Abbott’s FreeStyle Libre technology with insulin dosing information for smart pens, insulin titration apps and cloud software. […]

Filed Under: Diabetes, Diagnostics Tagged With: Abbott, Medtronic, Novo Nordisk, Sanofi

Cigna lowers insulin price to $25 per month

April 3, 2019 By Nancy Crotti

Under pressure from patients and the FDA, Cigna (NYSE:CI) and Express Scripts said today that they will lower the price of insulin to $25 per month for some patients. Three firms — Eli Lilly, Novo Nordisk and Sanofi — control 90% of the global insulin market and produce all the insulin used in the U.S. […]

Filed Under: Business/Financial News, Diabetes, Featured, Food & Drug Administration (FDA), News Well, Pharmaceutical, Regulatory/Compliance Tagged With: Cigna, Eli Lilly & Co., Express Scripts, FDA, Novo Nordisk, Sanofi

Novo Nordisk seeks FDA nod for oral diabetes pill

March 21, 2019 By Sarah Faulkner

Novo Nordisk (NYSE:NVO) said this week that it submitted applications to the FDA for its oral formulation of semaglutide, a once-daily glucagon-like peptide-1 receptor agonist therapy. The company is hoping its pill will be approved as an adjunct to diet and exercise to improve blood sugar control in adults with Type 2 diabetes. Novo Nordisk also […]

Filed Under: Business/Financial News, Diabetes, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance, Wall Street Beat Tagged With: Novo Nordisk

Glooko, Novo Nordisk team up for connected insulin pens

February 25, 2019 By Sarah Faulkner

Glooko announced this month that it’s teaming up to connect Novo Nordisk‘s (NYSE:NVO) insulin pens with the company’s diasend diabetes management solution. Novo Nordisk plans to launch its connected insulin pens, the NovoPen 6 and NovoPen Echo Plus, in early 2019. Any provider using diasend and any person using the diasend mobile app will be able to sync […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Dexcom, Glooko, Insulet, Novo Nordisk

Abbott, Novo Nordisk ink deal for digital diabetes tools

February 20, 2019 By Sarah Faulkner

Abbott (NYSE:ABT) said today that it inked a non-exclusive deal to integrate insulin dose data from Novo Nordisk‘s (NYSE:NVO) pre-filled and connected pens with its FreeStyle Libre mobile app and cloud-based system. The companies touted that integrating the products will allow healthcare professionals, caregivers and users to easily view glucose and insulin data, as well as make […]

Filed Under: Business/Financial News, Diabetes, Digital Health, Drug-Device Combinations, Featured, Pharmaceutical, Wall Street Beat Tagged With: Abbott, Novo Nordisk

Study: Researchers develop ingestible capsule for insulin delivery

February 11, 2019 By Sarah Faulkner

A team of researchers from MIT developed an ingestible, blueberry-sized capsule that can deliver insulin orally. In animal models, the capsule lowered blood sugar levels and performed comparably with the traditional route of insulin delivery – injections. The capsule features a small needle made of freeze-dried, compressed insulin. The needle is attached to a compressed spring, which […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceutical, Research & Development Tagged With: Brigham & Women's Hospital, Massachusetts Institute of Technology, National Institutes of Health (NIH), Novo Nordisk

Pharma stocks fall as Rep. Cummings launches drug pricing investigation

January 14, 2019 By Sarah Faulkner

Chairman of the House Oversight Committee Rep. Elijah Cummings (D-MD) launched an investigation today into the drug pricing practices of 12 pharmaceutical companies. A number of companies named in the investigation saw their stock prices fall, including Amgen (NSDQ:AMGN), AbbVie (NYSE:ABBV), AstraZeneca (NYSE:AZN), Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO). A hearing is reportedly set for Jan. 29 and will include patients affected by rising […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceutical, Wall Street Beat Tagged With: AbbVie, Amgen, AstraZeneca plc, Eli Lilly & Co., Novo Nordisk, Sanofi-Aventis

Novo Nordisk partners with Flex for digital diabetes management tools

October 23, 2018 By Sarah Faulkner

Flex (NSDQ:FLEX) today announced a partnership with Novo Nordisk (NYSE:NVO) to develop digital diabetes management tools using Flex’s BrightInsight IoT platform. Novo Nordisk plans to use Flex’s BrightInsight system to build and manage connected medical devices and the corresponding data. The company’s IoT platform is designed to enable organizations to develop digital health devices while remaining compliant with […]

Filed Under: Big Data, Diabetes, Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Novo Nordisk

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 8
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS

  1. themes/genesis/config/layouts.php
  2. themes/genesis/config/requirements.php
  3. themes/genesis/footer.php
  4. themes/genesis/functions.php
  5. themes/genesis/header.php
  6. themes/genesis/lib/admin/term-meta.php
  7. themes/genesis/lib/admin/user-meta.php
  8. themes/genesis/lib/classes/class-genesis-requirements-views.php
  9. themes/genesis/lib/classes/class-genesis-script-loader.php
  10. themes/genesis/lib/classes/class-genesis-search-form.php
  11. themes/genesis/lib/css/load-styles.php
  12. themes/genesis/lib/framework.php
  13. themes/genesis/lib/functions/breadcrumb.php
  14. themes/genesis/lib/functions/compat.php
  15. themes/genesis/lib/functions/deprecated.php
  16. themes/genesis/lib/functions/feed.php
  17. themes/genesis/lib/functions/formatting.php
  18. themes/genesis/lib/functions/general.php
  19. themes/genesis/lib/functions/head.php
  20. themes/genesis/lib/functions/image.php
  21. themes/genesis/lib/functions/layout.php
  22. themes/genesis/lib/functions/markup.php
  23. themes/genesis/lib/functions/menu.php
  24. themes/genesis/lib/functions/open-graph.php
  25. themes/genesis/lib/functions/options.php
  26. themes/genesis/lib/functions/post-meta.php
  27. themes/genesis/lib/functions/requirements.php
  28. themes/genesis/lib/functions/rest.php
  29. themes/genesis/lib/functions/seo.php
  30. themes/genesis/lib/functions/toolbar.php
  31. themes/genesis/lib/functions/upgrade.php
  32. themes/genesis/lib/functions/version.php
  33. themes/genesis/lib/functions/widgetize.php
  34. themes/genesis/lib/init.php
  35. themes/genesis/lib/js/load-scripts.php
  36. themes/genesis/lib/shortcodes/footer.php
  37. themes/genesis/lib/shortcodes/post.php
  38. themes/genesis/lib/structure/archive.php
  39. themes/genesis/lib/structure/comments.php
  40. themes/genesis/lib/structure/footer.php
  41. themes/genesis/lib/structure/header.php
  42. themes/genesis/lib/structure/layout.php
  43. themes/genesis/lib/structure/loops.php
  44. themes/genesis/lib/structure/menu.php
  45. themes/genesis/lib/structure/post.php
  46. themes/genesis/lib/structure/sidebar.php
  47. themes/genesis/lib/widgets/featured-page-widget.php
  48. themes/genesis/lib/widgets/featured-post-widget.php
  49. themes/genesis/lib/widgets/user-profile-widget.php
  50. themes/genesis/lib/widgets/widgets.php
  51. themes/genesis/searchform.php
  52. themes/genesis/sidebar.php
  53. themes/news-pro/functions.php
  54. themes/news-pro/lib/customize.php
  55. themes/news-pro/lib/helper-functions.php
  56. themes/news-pro/lib/output.php
  57. themes/news-pro/lib/theme-defaults.php
  58. themes/news-pro/lib/woocommerce/woocommerce-notice.php
  59. themes/news-pro/lib/woocommerce/woocommerce-output.php
  60. themes/news-pro/lib/woocommerce/woocommerce-setup.php